Unknown

Dataset Information

0

Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763).

ABSTRACT: BACKGROUND:Recipients of hematopoietic stem cell transplantation (HSCT) are among the highest consumers of allogeneic red blood cell (RBC) and platelet (PLT) components. The impact of patient blood management (PBM) efforts on HSCT recipients is poorly understood. STUDY DESIGN AND METHODS:This observational study assessed changes in blood product use and patient-centered outcomes before and after implementing a multidisciplinary PBM program for patients undergoing HSCT at a large academic medical center. The pre-PBM cohort was treated from January 1 through September 31, 2013; the post-PBM cohort was treated from January 1 through September 31, 2015. RESULTS:We identified 708 patients; 284 of 352 (80.7%) in the pre-PBM group and 225 of 356 (63.2%) in the post-PBM group received allogeneic RBCs (p?

SUBMITTER: Warner MA 

PROVIDER: S-EPMC6813829 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763).

Warner Matthew A MA   Jambhekar Nilesh S NS   Saadeh Salwa S   Jacob Eapen K EK   Kreuter Justin D JD   Mundell William C WC   Marquez Alberto A   Higgins Andrew A AA   Madde Nageswar R NR   Hogan William J WJ   Kor Daryl J DJ  

Transfusion 20190620 9

<h4>Background</h4>Recipients of hematopoietic stem cell transplantation (HSCT) are among the highest consumers of allogeneic red blood cell (RBC) and platelet (PLT) components. The impact of patient blood management (PBM) efforts on HSCT recipients is poorly understood.<h4>Study design and methods</h4>This observational study assessed changes in blood product use and patient-centered outcomes before and after implementing a multidisciplinary PBM program for patients undergoing HSCT at a large a  ...[more]

Similar Datasets

Unknown Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation.
| S-EPMC9344644 | biostudies-literature
Unknown Management of uterine bleeding during hematopoietic stem cell transplantation.
| S-EPMC3798064 | biostudies-literature
Unknown Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.
| S-EPMC3811179 | biostudies-literature
Unknown Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.
| S-EPMC3285188 | biostudies-literature
Unknown Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives
| S-EPMC7526064 | biostudies-literature
Unknown RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.
| S-EPMC2974591 | biostudies-literature
Unknown Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.
| S-EPMC3830830 | biostudies-literature
Unknown Exploring the caregiver's experience in an innovative homebound hematopoietic stem cell transplantation program.
| S-EPMC9250147 | biostudies-literature
Unknown Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.
| S-EPMC3257831 | biostudies-literature
Unknown Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.
| S-EPMC5803310 | biostudies-literature